Trabeculectomy Technique with Mitomycin-C Ike Ahmed
15:13
Trabeculectomy with Mitomycin C, Ologen & Anti VEGF
13:36
Pharmacology - CANCER DRUGS – CELL CYCLE SPECIFIC AND NONSPECIFIC AGENTS (MADE EASY)
1:58
Mitomycin Ophthalmic 0.3mg/mL dilution
Mitomycin C is a mitomycin that is used as a chemotherapeutic agent by virtue of its antitumour activity. It is given intravenously to treat upper gastro-intestinal cancers, anal cancers, and breast cancers, as well as by bladder instillation for superficial bladder tumours. It causes delayed bone marrow toxicity and therefore it is usually administered at 6-weekly intervals. Prolonged use may result in permanent bone-marrow damage. It may also cause lung fibrosis and renal damage.